Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 9, 2025British Journal of Hospital MedicineOpen Access

Management of SGLT-2 Inhibitors in the Perioperative Period: Withhold or Continue?

View Full Paper
Ask AI
Bookmark
Share

Authors

ZPZack Pittack

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zack Pittack (2025) studied this question.

synapsesocial.com/papers/6a0277537247e11d6d512cbfhttps://doi.org/10.12968/hmed.2024.0611
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors2023 · 163 citations
  2. 2SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection2022 · 168 citations
  3. 3Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports2023 · 57 citations
  4. 4Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes2015 · 12,315 citations
  5. 5Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program2015 · 326 citations